The Health Policy Project ended in 2016. Work continued under Health Policy Plus (HP+) until 2022.
PUBLICATION
Author(s): Sayaka Koseki and Sara Bowsky
Primary Language: English
Date: 8/15/2015
Abstract:
The USAID- and PEPFAR-funded Health Policy Project partnered with the government of Côte d’Ivoire and PEPFAR on a study to estimate the cost and impact of HIV treatment scale-up by calculating the cost of antiretroviral treatment (ART) for one person per year for adults, children, and pregnant women. This annual ART cost was analyzed as a function of regimen, stage of illness at treatment initiation, retention, and response to treatment. The average cost was used to project the total investment necessary to scale up ART between 2015 and 2020 and achieve the country’s 90-90-90 goal, in which 90 percent of people living with HIV know their status, 90 percent of those diagnosed with HIV are on treatment, and 90 percent of those on treatment are virally suppressed. Using the Spectrum suite of policy models, the study estimated the number of lives saved and pediatric infections averted if this treatment scaleup is achieved. This study fills the critical information gap on cost as it relates to outcome. The government of Côte d’Ivoire and its development partners will be able to understand the resource needs for treatment scale-up and have the necessary data to inform decision making to effectively target available resources for HIV treatment.
Brief Costing HIV Côte d'Ivoire West Africa
